A5082350484- Diabetes Treatment and Management
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Pancreatic function and diabetes
- Pharmacology and Obesity Treatment
- Pharmaceutical Practices and Patient Outcomes
- Chronic Kidney Disease and Diabetes
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet and metabolism studies
- Diabetes and associated disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Medication Adherence and Compliance
- Peptidase Inhibition and Analysis
- Pharmaceutical studies and practices
- Blood Pressure and Hypertension Studies
- Obesity and Health Practices
- Dialysis and Renal Disease Management
- Patient Safety and Medication Errors
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Neuropeptides and Animal Physiology
- Immune Response and Inflammation
- Inhalation and Respiratory Drug Delivery
- Potassium and Related Disorders
Washington State University Spokane
2016-2025
Providence College
2019-2025
Sisters of Providence Health System
2025
Inland Northwest Health Services
2023-2025
Providence Health & Services
2019-2024
Providence Regional Medical Center Everett
2023
Washington State University
2006-2023
RELX Group (United States)
2022
University of Southern California
2021
University of California, San Diego
2019
There is no standard meal plan or eating pattern that works universally for all people with diabetes. In order to be effective, nutrition therapy should individualized each patient/client based on his her individual health goals; personal and cultural preferences; literacy numeracy; access healthful choices; readiness, willingness, ability change. Nutrition interventions emphasize a variety of minimally processed nutrient dense foods in appropriate portion sizes as part provide the diabetes...
The incidence and prevalence of diabetes mellitus have grown significantly throughout the world, due primarily to increase in type 2 diabetes. This overall number people with has had a major impact on development diabetic kidney disease (DKD), one most frequent complications both types DKD is leading cause end-stage renal (ESRD), accounting for approximately 50% cases developed world. Although rates ESRD attributable recently stabilized, these continue rise high-risk groups such as...
<h3>Importance</h3> Chronic kidney disease (CKD) is serious and common, yet recognition public health responses are limited. <h3>Objective</h3> To describe clinical features of, prevalence major risk factors for, care for CKD among patients treated in 2 large US systems. <h3>Design, Setting, Participants</h3> This cohort study collected data from the Center Kidney Disease Research, Education, Hope (CURE-CKD) registry, an electronic record–based registry jointly curated sponsored by...
Unexpected drug shortages of the long-acting glucagon-like peptide-1 (GLP-1) receptor agonists dulaglutide and semaglutide dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonist tirzepatide emerged in late 2022 have persisted through first quarter 2023 (1). The shortage has not affected product doses equally; some are more widely available than others (2). For purposes this article, we will consider GLP-1/GIP to be included when referring GLP-1 shortages. These predominately...
Abstract Aim Guideline‐directed medical therapy (GDMT) is designed to improve clinical outcomes. The study aim was assess GDMT prescribing rates and prescribing‐persistence predictors in patients with diabetes chronic kidney disease (CKD) from the Center for Kidney Disease Research, Education, Hope Registry. Materials Methods Data were obtained adults ≥18 years old CKD between 1 January 2019 31 December 2020 (N = 39 158). Baseline persistent (≥90 days) prescriptions GDMT, including...
OBJECTIVE To characterize contemporary trends in glucagon fill rates and expenditures a nationwide cohort of adults with diabetes overall by key demographic clinical characteristics. RESEARCH DESIGN AND METHODS In this retrospective study, we examined 1) per 1,000 person-years 2) patient out-of-pocket health plan costs filled dose among included OptumLabs Data Warehouse between 1 January 2011 31 March 2021. RESULTS The study population comprised 2,814,464 mean age 62.8 (SD 13.2) years. rate...
During times of transition, the pharmaceutical care patients receive is often suboptimal and wrought with danger. Home healthcare nurses play a pivotal important role in providing transitional to by identifying resolving medication discrepancies. Nurses must partner pharmacists, physicians, others involved transitions decrease likelihood experiencing untoward health consequences associated medications. "Care team sport, yet all too we don't know who our teammates are, or how they can help."...